Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

May 14, 2019

SELL
$105.93 - $142.47 $233,575 - $314,146
-2,205 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$128.36 - $272.13 $283,033 - $600,046
2,205 New
2,205 $605,000
Q3 2018

Oct 31, 2018

SELL
$211.18 - $274.49 $116,149 - $150,969
-550 Closed
0 $0
Q1 2018

Apr 03, 2018

BUY
$138.63 - $182.62 $76,246 - $100,441
550 New
550 $91,000

Others Institutions Holding LGND

About LIGAND PHARMACEUTICALS INC


  • Ticker LGND
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 16,882,800
  • Market Cap $1.91B
  • Description
  • Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...
More about LGND
Track This Portfolio

Track Usa Financial Portformulas Corp Portfolio

Follow Usa Financial Portformulas Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Usa Financial Portformulas Corp, based on Form 13F filings with the SEC.

News

Stay updated on Usa Financial Portformulas Corp with notifications on news.